Cargando…

Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study

Detalles Bibliográficos
Autores principales: Wang, Miao, Cao, Han-Yu, Tan, Kai-Wen, Qiu, Qiao-Cheng, Huang, Yuan-Hong, Ge, Shuai-shuai, Wang, Zi-Hao, Chen, Jia, Tang, Xiao-Wen, Wu, De-Pei, Xue, Sheng-Li, Li, Zheng, Dai, Hai-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682468/
https://www.ncbi.nlm.nih.gov/pubmed/38012154
http://dx.doi.org/10.1038/s41408-023-00948-x
_version_ 1785150982229852160
author Wang, Miao
Cao, Han-Yu
Tan, Kai-Wen
Qiu, Qiao-Cheng
Huang, Yuan-Hong
Ge, Shuai-shuai
Wang, Zi-Hao
Chen, Jia
Tang, Xiao-Wen
Wu, De-Pei
Xue, Sheng-Li
Li, Zheng
Dai, Hai-Ping
author_facet Wang, Miao
Cao, Han-Yu
Tan, Kai-Wen
Qiu, Qiao-Cheng
Huang, Yuan-Hong
Ge, Shuai-shuai
Wang, Zi-Hao
Chen, Jia
Tang, Xiao-Wen
Wu, De-Pei
Xue, Sheng-Li
Li, Zheng
Dai, Hai-Ping
author_sort Wang, Miao
collection PubMed
description
format Online
Article
Text
id pubmed-10682468
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106824682023-11-30 Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study Wang, Miao Cao, Han-Yu Tan, Kai-Wen Qiu, Qiao-Cheng Huang, Yuan-Hong Ge, Shuai-shuai Wang, Zi-Hao Chen, Jia Tang, Xiao-Wen Wu, De-Pei Xue, Sheng-Li Li, Zheng Dai, Hai-Ping Blood Cancer J Correspondence Nature Publishing Group UK 2023-11-27 /pmc/articles/PMC10682468/ /pubmed/38012154 http://dx.doi.org/10.1038/s41408-023-00948-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Wang, Miao
Cao, Han-Yu
Tan, Kai-Wen
Qiu, Qiao-Cheng
Huang, Yuan-Hong
Ge, Shuai-shuai
Wang, Zi-Hao
Chen, Jia
Tang, Xiao-Wen
Wu, De-Pei
Xue, Sheng-Li
Li, Zheng
Dai, Hai-Ping
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
title Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
title_full Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
title_fullStr Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
title_full_unstemmed Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
title_short Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
title_sort venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with runx1::runx1t1: a retrospective propensity score matching study
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682468/
https://www.ncbi.nlm.nih.gov/pubmed/38012154
http://dx.doi.org/10.1038/s41408-023-00948-x
work_keys_str_mv AT wangmiao venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT caohanyu venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT tankaiwen venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT qiuqiaocheng venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT huangyuanhong venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT geshuaishuai venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT wangzihao venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT chenjia venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT tangxiaowen venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT wudepei venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT xueshengli venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT lizheng venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy
AT daihaiping venetoclaxplushypomethylatingagentsinnewlydiagnosedacutemyeloidleukemiapatientswithrunx1runx1t1aretrospectivepropensityscorematchingstudy